CN1043994C - 噻吩并苯并二氮草类化合物及其制法和用途 - Google Patents

噻吩并苯并二氮草类化合物及其制法和用途 Download PDF

Info

Publication number
CN1043994C
CN1043994C CN93108212A CN93108212A CN1043994C CN 1043994 C CN1043994 C CN 1043994C CN 93108212 A CN93108212 A CN 93108212A CN 93108212 A CN93108212 A CN 93108212A CN 1043994 C CN1043994 C CN 1043994C
Authority
CN
China
Prior art keywords
compound
alkyl
methyl
thieno
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93108212A
Other languages
English (en)
Chinese (zh)
Other versions
CN1085903A (zh
Inventor
J·费尔赫斯特
D·E·塔帕
T·M·霍顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929211379A external-priority patent/GB9211379D0/en
Priority claimed from GB939309025A external-priority patent/GB9309025D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of CN1085903A publication Critical patent/CN1085903A/zh
Application granted granted Critical
Publication of CN1043994C publication Critical patent/CN1043994C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN93108212A 1992-05-29 1993-05-28 噻吩并苯并二氮草类化合物及其制法和用途 Expired - Fee Related CN1043994C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9211379.4 1992-05-29
GB929211379A GB9211379D0 (en) 1992-05-29 1992-05-29 Pharmaceutical compounds
GB9309025.6 1993-04-30
GB939309025A GB9309025D0 (en) 1993-04-30 1993-04-30 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
CN1085903A CN1085903A (zh) 1994-04-27
CN1043994C true CN1043994C (zh) 1999-07-07

Family

ID=26300951

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93108212A Expired - Fee Related CN1043994C (zh) 1992-05-29 1993-05-28 噻吩并苯并二氮草类化合物及其制法和用途

Country Status (21)

Country Link
EP (1) EP0582368B1 (OSRAM)
JP (1) JP3219541B2 (OSRAM)
CN (1) CN1043994C (OSRAM)
AT (1) ATE198891T1 (OSRAM)
AU (1) AU668159B2 (OSRAM)
CA (1) CA2097016A1 (OSRAM)
CZ (1) CZ282783B6 (OSRAM)
DE (1) DE69329887T2 (OSRAM)
DK (1) DK0582368T3 (OSRAM)
ES (1) ES2153373T3 (OSRAM)
FI (1) FI101538B (OSRAM)
GR (1) GR3035587T3 (OSRAM)
HU (1) HU218278B (OSRAM)
IL (1) IL105827A (OSRAM)
MX (1) MX9303124A (OSRAM)
MY (1) MY109943A (OSRAM)
NO (1) NO305125B1 (OSRAM)
NZ (1) NZ247703A (OSRAM)
PT (1) PT582368E (OSRAM)
RU (1) RU2125574C1 (OSRAM)
TW (1) TW268005B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US6258807B1 (en) * 1996-03-25 2001-07-10 Eli Lilly And Company Method for treating pain
EA000976B1 (ru) * 1996-03-25 2000-08-28 Эли Лилли Энд Компани Композиция для снятия боли и способ снятия боли
JP2001508759A (ja) * 1996-03-25 2001-07-03 イーライ・リリー・アンド・カンパニー 片頭痛の処置法
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
CA2266444C (en) 1996-09-23 2007-01-09 Eli Lilly And Company Olanzapine dihydrate d
JP2001501207A (ja) * 1996-09-24 2001-01-30 イーライ・リリー・アンド・カンパニー コーティングされた粒子製剤
RU2185383C1 (ru) * 2001-05-22 2002-07-20 Институт молекулярной генетики РАН ВЫСОКОМЕЧЕННЫЙ ТРИТИЕМ 2-МЕТИЛ-4-(4-МЕТИЛ-1-ПИПЕРАЗИНИЛ)-10Н-ТИЕНО[2,3-b][1,5]БЕНЗОДИАЗЕПИН
CA2882555C (en) 2012-08-21 2018-11-06 Janssen Pharmaceutica Nv Haptens of paliperidone
HK1211958A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
EP2888257B1 (en) 2012-08-21 2017-08-02 Janssen Pharmaceutica NV Haptens of quetiapine for use in immunoassays
EP2888592B1 (en) 2012-08-21 2017-11-08 Janssen Pharmaceutica NV Antibodies to quetiapine and use thereof
PT2888234T (pt) 2012-08-21 2018-02-22 Janssen Pharmaceutica Nv Haptenos de aripiprazol e seu uso em imunoensaios
JP6131500B2 (ja) 2012-08-21 2017-05-24 ヤンセン ファーマシューティカ エヌ．ベー． リスペリドン及びパリペリドンのハプテン
EP2888287A4 (en) 2012-08-21 2016-04-20 Ortho Clinical Diagnostics Inc ANTIBODIES AGAINST PALIPERIDONE HAPTENES AND THEIR USE
AU2013305901B2 (en) 2012-08-21 2017-10-26 Saladax Biomedical Inc. Antibodies to olanzapine and use thereof
PL3385284T3 (pl) 2012-08-21 2020-09-21 Janssen Pharmaceutica Nv Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
CN104737017B (zh) 2012-08-21 2017-03-08 詹森药业有限公司 利培酮的抗体及其用途
EP3663316A1 (en) 2012-08-21 2020-06-10 Janssen Pharmaceutica NV Antibodies to aripiprazole and use thereof
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ．ベー． アリピプラゾールハプテンに対する抗体及びその使用
TR201910347T4 (tr) 2012-08-21 2019-07-22 Janssen Pharmaceutica Nv Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı.
PT2888284T (pt) 2012-08-21 2022-11-18 Janssen Pharmaceutica Nv Anticorpos dirigidos contra haptenos de risperidona e a sua utilização
US9303041B2 (en) * 2012-08-21 2016-04-05 Janssen Pharmaceutica Nv Haptens of olanzapine
WO2017106508A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
CA3008809A1 (en) 2015-12-17 2017-06-22 Janssen Pharmaceutica Nv Antibodies to risperidone and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569731A5 (OSRAM) * 1972-04-04 1975-11-28 Wander Ag Dr A
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4061752A (en) * 1975-08-06 1977-12-06 Sandoz Ltd. 6-Piperazino-11-methylene-dibenzazepines[b,e]
DE2641378A1 (de) * 1975-09-24 1977-04-07 Sandoz Ag Neue organische verbindungen, ihre verwendung und herstellung
CH624682A5 (OSRAM) * 1976-11-10 1981-08-14 Sandoz Ag
US4761411A (en) * 1983-05-18 1988-08-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
GR3035587T3 (en) 2001-06-29
FI101538B1 (fi) 1998-07-15
NO931917L (no) 1993-11-30
FI932445L (fi) 1993-11-30
TW268005B (OSRAM) 1996-01-11
RU2125574C1 (ru) 1999-01-27
AU3980793A (en) 1993-12-02
NO931917D0 (no) 1993-05-26
FI101538B (fi) 1998-07-15
AU668159B2 (en) 1996-04-26
CZ282783B6 (cs) 1997-10-15
ATE198891T1 (de) 2001-02-15
PT582368E (pt) 2001-05-31
CZ102493A3 (en) 1993-12-15
HU9301579D0 (en) 1993-09-28
MY109943A (en) 1997-10-31
DE69329887D1 (de) 2001-03-01
CA2097016A1 (en) 1993-11-30
NO305125B1 (no) 1999-04-06
IL105827A (en) 1997-02-18
HU218278B (en) 2000-07-28
ES2153373T3 (es) 2001-03-01
JP3219541B2 (ja) 2001-10-15
NZ247703A (en) 1995-07-26
JPH0687862A (ja) 1994-03-29
MX9303124A (es) 1993-11-01
IL105827A0 (en) 1993-09-22
FI932445A0 (fi) 1993-05-28
CN1085903A (zh) 1994-04-27
HUT66180A (en) 1994-09-28
EP0582368B1 (en) 2001-01-24
DK0582368T3 (da) 2001-02-05
DE69329887T2 (de) 2001-05-23
EP0582368A1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
CN1043994C (zh) 噻吩并苯并二氮草类化合物及其制法和用途
RU2591194C2 (ru) Органические соединения
CN101573333B (zh) 组蛋白脱乙酰酶抑制剂
HU211575A9 (en) 2-methyl-thieno-benzodiazepine
EP0836688A2 (de) Rotierendes ventil mit schrägem zugang
US6034078A (en) Thienobenzodiazepine compounds
US7407966B2 (en) Thienopyridinone compounds and methods of treatment
CN102712643A (zh) 5-ht受体的调节剂及其使用方法
CN1158127A (zh) 新的n-聚代萘并稠合内酰胺
JPH0764821B2 (ja) ベンゾアゼピン誘導体
CN1085667C (zh) 对5－ht2受体具亲合性的取代四环氮杂䓬衍生物
CN1321158A (zh) 作为药物的三环△3－哌啶
KR100287933B1 (ko) 5-ht3-수용체 길항제로서의 2,6-메타노-2h-퀴놀리진 유도체,이의 제조방법 및 이를 포함하는 약제학적 조성물
US4673674A (en) Diazepinoindoles useful for treating depression, schizophrenia, social withdrawal or anxiety and pharmaceutical compositions containing them
KR100273622B1 (ko) 티에노벤조디아제핀 유도체, 이의 제조방법 및 이를 포함하는 약제학적 제형
CN1331692A (zh) 作为α2－拮抗剂的苯并异噁唑和苯基酮
RU2176914C2 (ru) Способ лечения нарушения познавательной функции
JP3034556B2 (ja) 医薬用化合物類
CS249455B1 (en) N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo(b,f)thiepines and their salts and method of their preparation
JPH09507849A (ja) 神経性情報の処理方法
JPWO1996025416A1 (ja) チオフェン化合物およびその医薬用途
WO1996025416A1 (en) Thiophene compounds and medicinal use thereof
JP2003513086A (ja) ５ｈｔ受容体関連障害治療用ベンゾ［ｆ］インドール類

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee